✦ LIBER ✦

Polyamine biosynthesis inhibitors combined with systemic hyperthermia in cancer therapy

✍ Scribed by Paul M. Harari; David J.M. Fuller; Stephen W. Carper; Marilyn K. Croghan; Frank L. Meyskens jr.; David S. Shimm; Eugene W. Gerner

Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 925 KB
Volume: 19
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(90)90139-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for and initial clinical appli

Rationale for and initial clinical application of polyamine biosynthesis inhibitors combined with systemic hyperthermia in cancer therapy

✍ Paul M. Harari; David J.M. Fuller; Steven W. Carper; Marilyn K. Croghan; Frank L 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Urinary polyamine levels in cancer patie

Urinary polyamine levels in cancer patients treated with D,L-α-Difluoromethylornithine, an inhibitor of polyamine biosynthesis

✍ Dr. Yoav Horn; Lina Spigel; Laurence J. Marton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

The polyamine biosynthesis inhibitor D,L-a-Difluoromethylornithine hydrochloride monohydrate (DFMO) has cytostatic and cytotoxic effects against various human tumor cell lines in vitro. We measured levels of the polyamines putrescine and spermidine in the urine of cancer patients undergoing "convent

In vivo enhancement of herpes simplex vi

In vivo enhancement of herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibition

✍ Tiina Wahlfors; Tanja Hakkarainen; Juhani Jänne; Leena Alhonen; Jarmo Wahlfors 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB

## Abstract We have earlier demonstrated that inhibition of polyamine biosynthesis with difluoromethylornithine (DFMO) can be used to enhance the cytotoxicity of herpes simplex virus thymidine kinase/ganciclovir (HSV‐TK/GCV) gene therapy in different tumor cell lines. Here, the utility of this trea

Synergistic anti-proliferative and pro-a

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 1 views

## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i

Synergistic anti-proliferative and pro-a

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 1 views

Controlled systemic release of interleuk

Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas

✍ Gregor Tevz; Simona Kranjc; Maja Cemazar; Urska Kamensek; Andrej Coer; Mojca Krz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

## Abstract ## Background The present study aimed to evaluate the antitumor effectiveness of systemic __interleukin (IL)‐12__ gene therapy in murine sarcoma models, and to evaluate its interaction with the irradiation of tumors and metastases. To avoid toxic side‐effects of __IL‐12__ gene therapy,